Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
987.9 DKK | -0.59% | -0.31% | +41.51% |
09:45pm | Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says | RE |
02:16pm | Novo Nordisk Confirms WHO Coordination Amid Fake Ozempic Batches | MT |
ETFs positioned on Novo Nordisk A/S
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
21.31% | 218 M€ | +16.41% | ||
10.45% | 4 M€ | +14.47% | ||
5.40% | 21 M€ | +9.61% | - | |
4.67% | 88 M€ | +10.37% | - | |
3.95% | 4 M€ | -.--% | - | |
3.91% | 5 M€ | +10.09% | - | |
3.91% | 14 M€ | +5.66% | - | |
3.78% | 6 M€ | -.--% | ||
3.09% | 12 M€ | +15.09% | - | |
3.02% | 6 M€ | -.--% | - | |
2.87% | 29 M€ | +8.37% | - | |
2.53% | 3,859 M€ | +18.82% | - | |
2.53% | 469 M€ | -2.05% | ||
2.22% | 3 M€ | +9.95% | - | |
1.91% | 2 M€ | +9.19% | - | |
1.91% | 2 M€ | -.--% | - | |
1.67% | 10 M€ | -3.35% | - | |
1.60% | 10 M€ | +6.14% | - | |
1.31% | 252 M€ | +8.56% | ||
1.30% | 51 M€ | +7.06% | ||
1.04% | 276 M€ | +11.40% | - | |
1.03% | 7 M€ | +4.20% | - | |
0.89% | 1,056 M€ | +2.15% | ||
0.79% | 284 M€ | -.--% | ||
0.76% | 23 M€ | -.--% | - | |
0.76% | 786 M€ | -.--% | ||
0.75% | 206 M€ | -.--% | ||
0.70% | 7 M€ | +0.11% | - | |
0.64% | 261 M€ | -.--% | - | |
0.64% | 200 M€ | +10.50% | - | |
0.64% | 488 M€ | +16.80% | ||
0.57% | 749 M€ | +9.08% | ||
0.56% | 1,166 M€ | +0.26% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.51% | 633B | |
+52.13% | 798B | |
-5.02% | 356B | |
+19.54% | 328B | |
+10.39% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+7.17% | 166B | |
-3.44% | 157B |
- Stock Market
- Equities
- NOVO B Stock
- Funds and ETFs Novo Nordisk A/S